Invesco Ltd. Biogen Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Invesco Ltd. holds 2,320,126 shares of BIIB stock, worth $336 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,320,126

Previous 2,265,007 2.43%

Holding current value

$336 Million

Previous $310 Million 5.99%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$113.38 - $135.49 $6.25 Million - $7.47 Million	55,119 Added 2.43%	2,320,126 $291 Million
Q1 2025 May 12, 2025	BUY	$133.43 - $153.27 $18.2 Million - $20.9 Million	136,200 Added 6.4%	2,265,007 $310 Million
Q4 2024 Feb 13, 2025	BUY	$146.47 - $191.55 $73.1 Million - $95.6 Million	499,074 Added 30.62%	2,128,807 $326 Million
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $64.3 Million - $80.6 Million	340,290 Added 26.39%	1,629,733 $316 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $72.1 Million - $89.6 Million	-378,574 Reduced 22.7%	1,289,443 $299 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $31.1 Million - $39.3 Million	-146,649 Reduced 8.08%	1,668,017 $360 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $141 Million - $170 Million	633,292 Added 53.61%	1,814,666 $470 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $48 Million - $54.1 Million	189,368 Added 19.09%	1,181,374 $304 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $8.79 Million - $10.2 Million	-31,921 Reduced 3.12%	992,006 $283 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $26.5 Million - $30.2 Million	103,448 Added 11.24%	1,023,927 $285 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $12.7 Million - $15.4 Million	-50,297 Reduced 5.18%	920,479 $255 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $2.81 Million - $3.88 Million	14,436 Added 1.51%	970,776 $259 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $362,139 - $430,651	1,931 Added 0.2%	956,340 $195 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $34.2 Million - $43.1 Million	-176,654 Reduced 15.62%	954,409 $201 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $31.5 Million - $40.4 Million	140,484 Added 14.18%	1,131,063 $271 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $15 Million - $19.5 Million	-52,879 Reduced 5.07%	990,579 $280 Million
Q2 2021 Aug 17, 2021	BUY	$259.0 - $414.71 $2.44 Million - $3.91 Million	9,417 Added 0.91%	1,043,458 $361 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $47.1 Million - $55.2 Million	194,071 Added 23.1%	1,034,041 $289 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $14.4 Million - $21.7 Million	-61,055 Reduced 6.78%	839,970 $206 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $2.21 Million - $2.55 Million	-8,357 Reduced 0.92%	901,025 $256 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $9.04 Million - $12 Million	-34,958 Reduced 3.7%	909,382 $243 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $40.1 Million - $50.9 Million	-149,289 Reduced 13.65%	944,340 $299 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $391 Million - $540 Million	-1,774,755 Reduced 61.87%	1,093,629 $325 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $27.1 Million - $30.3 Million	-124,426 Reduced 4.16%	2,868,384 $668 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $52.5 Million - $57.9 Million	-239,523 Reduced 7.41%	2,992,810 $700 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $22.9 Million - $35.9 Million	105,853 Added 3.39%	3,232,333 $764 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $871 Million - $1.1 Billion	3,126,480 New	3,126,480 $941 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account